期刊文献+

人胎肾间充质样干细胞分离鉴定及其向脂肪和成骨细胞的分化 被引量:2

Isolation and identification of human fetal kidney-derived mesenchymal-like stem cells and their differentiation to adipocyte and osteoblast
暂未订购
导出
摘要 目的:分离纯化人胎肾中的间充质样干细胞,在化学因子作用下诱导其定向分化,并对其生物学特性进行初步鉴定。方法:实验于2005-10/2006-01在暨南大学医学院血液病研究所完成。①利用二步离心法、密度梯度离心法及细胞差速贴壁生长特性分离纯化人胎肾间充质样干细胞。细胞来源为自然流产胎儿,供者知情同意。②流式细胞仪检测其细胞周期和表面标志。③添加常规诱导液诱导其向脂肪分化犤以脂肪诱导分化液(DMEM/F12+体积分数为0.1的胎牛血清+1μmol/L地塞米松+5u/mL胰岛素+200μmol/L消炎痛)进行培养犦、成骨细胞分化(完全培养基中加入0.1μmol/L地塞米松,10mmol/Lβ-磷酸甘油,50μmol/L维生素C进行培养)并加以鉴定。结果:从人胎肾中成功分离纯化得到间充质样干细胞:①P6代细胞有79.1%的细胞处于静止期/DNA合成前期。②表达CD29,CD44,CD105和CD166,不表达造血细胞标志CD15,CD34,CD45。③不表达与移植物抗宿主病相关的HLA-DR,CD80,CD86,CD40,CD40L。④在向成骨分化的诱导液中培养后,间充质样干细胞发生形态变化,碱性磷酸酶染色阳性,出现钙结节;在脂肪诱导分化液内培养后,细胞形态发生变化,油红O染色阳性。结论:人胎肾中含有间充质样干细胞,人胎肾间充质样干细胞具有多向分化潜能,且免疫原性弱,可以作为组织工程和细胞治疗种子细胞的来源之一,但目前存在较难分离纯化,细胞产量不大的不足。 AIM: To isolate and purify the mesenchymal-like stem cells (MSCs) in human fetal kidney, and induce their oriented differentiation by chemical factors as well as primarily identify their biological characteristics. METHODS: The experiment was conducted at the Institute of Hematology, Medical College of Jinan University from October 2005 to January 2006. (1)Two-step centrifugation, density gradient centrifugation and characteristics of cell different adherence growth were used to isolate and purify the MSCs of human fetal kidney. The cells were obtained from aborted fetus, the providers of which all knew and agreed.(2)Flow cytometer was adopted to inspect the cell cycle and surface markers. (3)Regular inductive medium was added to induce the MSCs to differentiate to lipid [cultured with adipogenic inductive agents (DMEM/FI2 + 0.1 of fetal bovine serum + 1 μmol/L decaspray + 5μ/mL insulin + 200 μmol/L antinfan)] and osteoblast (The complete medium was added into 0.1 μmol/L decaspray, 10 mmol/L β-glycerol phophate, 50 μmoL/L vitamin C for culture), which were then identified. RESULTS: MSCs obtained from successful separation and purification of human fetal kidney:(1)79.1% of cells of passage 6 were at metabolic stage/ presynthetic phase. (2)The MSCs expressed CD29, CD44, CD105 and CD166, but not antigens of hematopoietic CD15, CD34 and CD45. (3)No antigen in the expression of MSCs is related with graft-versus-host disease (GVHD) such as HLA-DR, CD80, CD86, CD40 and CD40L.(4)Exposure of these cells to osteogenic inductive agents resulted in morphological changes of MSCs, positive expression after alkaline phosphatase staining and hydroxyapatite nodules. Incubation with adipogenic inductive agents resulted in morphological changes and positive results when staining with Oil Red O. CONCLUSION: There are MSCs in human fetal kidney, which have multi-differentiation potency and weaker immunogen, and it is one of the sources of tissue engineering and cell therapy. However, at present it is difficult to isolate and purity the MSCs, and the output is insufficient.
出处 《中国临床康复》 CAS CSCD 北大核心 2006年第25期17-20,共4页 Chinese Journal of Clinical Rehabilitation
基金 国务院侨办重点学科建设基金(2005) 广东省自然科学重点基金(021195)~~
  • 相关文献

参考文献14

  • 1Pittenger MF, Mackay AM,Beck SC,et al.Multilineage potential of adult human mesenchymal stem cells.Science 1999;284(5411):143-7
  • 2Deans RJ, Moseley AB. Mesenchymal stem cells: biology and potential clinical uses. Exp Hematol 2000;28(8):875-84
  • 3Mackenzie TC, Flake AW. Multilineage differentiation of human MSC after in utero transplantation. Cytotherapy 2001 ;3(5): 403-5
  • 4Jiang Y, Jahagirdar BN, Reinhardt RL, et al. Pluripotency of mesenchymal stem cells derived from adult marrow.Nature 2002;418:41-9
  • 5Noort WA,Kruisselbrink AB,Anker PS,et al. Mesenchymal stem cells promote engraftment of human umbilical cord blood derived CD34^+ cells in NOD/SCID mice.Exp Hematol 2002;30(8):870-8
  • 6Angelopoulou M,Novelli E,Grove J E,et al.Cotransplantation of human mesenchymal stem cells enhances human myelopoiesis and megakaryocytopoiesis in NOD/SCID mice.Exp Hematol 2003 ; 31(5):413-20
  • 7Pittinger M,Mackay A,Beck S, et al.Multilineage potential of adult human mesenchymal stem cells. Science 1999;284:143-7
  • 8Bruder SP,Jaiswal N,Haynestorth SE. Growth kinetics,selfronewal,and the osteogenic potential of purified human mesenchymal stem cells during extensive subcultivation and following cryopreservation.J Cell biochem 1997;64:278-94
  • 9陈纯.CD40-CD40L在移植免疫中的研究进展[J].国外医学(输血及血液学分册),2001,24(3):217-220. 被引量:7
  • 10Tamir A, Perocelli T, Stetler K,et al.Stem cell factor inhibits erythroid differentiation by modulating the activity of G1-cyclin-dependent kinase complexes:A role for p27 in ery- throid differntiation coupled G1 arrest.Cell Growth Differ 2000; 11:269-277

二级参考文献23

  • 1Huveneers-oorsprong MBM, Hoogenboom LAP, Kuiper HA. The use of the MTT test for determining the cytotoxicity of veterinary drugs in pig hepatocytes. Toxicol Vitro, 1997, (11) : 385-392.
  • 2Taub M, Primary kidney cells, Methods Mol Biol, 1997, 75:153-161.
  • 3Lyerla TA, Gross SK, Shea TB, Biochemical and morphological characterization of primary kidney cell cultures from beige mutant mice.Cell Tissue Res, 1987, 250(3) : 627-632.
  • 4Rosenberg MR, Miehalopoulos G. Kidney proximal tubular cells isolated by collagenase perfusion grow in defined media in the absence of growth factors, J Cell Physiol, 1987, 131(1): 107-113.
  • 5Muckter H, Islambouli S, Doklea E, et al. Isolated rat kidney tubules as a screening system for arsenic antidotes. Toxicol Appl Pharmacol, 1993,121(1): 118-128.
  • 6Tropepe c, Hitoshi S, sirard ch, et al. Direct neural fate specification from embryonic stem cells: Aprimitive mammalian naural stem cell stage acquired through a default mechanism[J].neuron,2001,30:65-78.
  • 7Massague J. ye-Guang.ch. Controlling TGF-β Signaling[J]. Genes & Dev.2000,14:627-644.
  • 8Panchision DM,Pickel JM,Studer L, et al. sequential actions of BMP receptors control neural precursor cell production and fate[J].Genes & Dev,2001,15:2094-2110.
  • 9Sun y; Nadal-vicens M, Misono S, et al. Neurogenin promotes neurogenesis and inhibits glial differentiation by independent mechanisms[J].Cell. 2001,104:365-376.
  • 10Jin HK, Carter JE, Huntley GW,et al. Intracerebral transplantation of mesenchymal stem cells into acid sphingomyelinase-deficient mice delays the onset of neurological abnormalities and extends their life span[J]. J Clin Invest, 2002, 109:1183-1891.

共引文献40

同被引文献54

  • 1薛群,张学光,苗宗宁,华军,曲静,王明元,施勤,陈永井,方振羊.胎盘间充质干细胞样细胞的培养及生物学特性的实验研究[J].苏州大学学报(医学版),2005,25(2):188-192. 被引量:8
  • 2孙强,邱勇.转录因子Runx2、Osterix与骨髓间质干细胞的成骨分化[J].江苏医药,2006,32(7):657-659. 被引量:6
  • 3姚旺祥,裴国献,刘勇,梅良斌,马安.兔胎盘源性间充质干祖细胞的分离方法比较[J].生物医学工程与临床,2007,11(2):85-87. 被引量:13
  • 4王跃春,张洹.人胎肝MSCs的分离、鉴定及其向脂肪和成骨细胞的分化[J].暨南大学学报(自然科学与医学版),2007,28(2):120-123. 被引量:3
  • 5Caplan AI. Mesenchymal stem cells. J Orthop Res. 1991 ;9 (5): 641-650.
  • 6Ookura N, Fujimori Y, Nishioka K, et al. Adipocyte differentiation of human marrow mesenchymal stem cells reduces the supporting capacity for hematopoietic progenitors but not for severe combined immunodeficiency repopulating cells. Int J Mol Med .2007;19(3):387-392.
  • 7Hoogduijn M J, Crop M J, Peeters AM, et al. Human heart, spleen, and perirenal fat-derived mesenchymal stem cells have immunomodulatory capacities. Stem Cells Dev. 2007;16(4):597-604.
  • 8Markov V, Kusumi K, Tadesse MG, et al. Identification of cord blood-derived mesenchymal stem/stromal cell populations with distinct growth kinetics, differentiation potentials, and gene expression profiles. Stem Cells Dev. 2007;16(1 ):53-73.
  • 9Romanov YA, Svintsitskaya VA, Smirnov VN. Searching for alternative sources of postnatal human mesenchymdal stem cells: candidate MSC-like cells from umbilical cord. Stem Cells. 2003;21 (1): 105-110.
  • 10Fukuchi Y, Nakajima H, Sugiyama D, et al. Human Placenta-Derived Cells Have Mesenchymal Stem/Progenitor Cell Potential. Stem Cells. 2004= 22(5): 649-658.

引证文献2

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部